Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 Apr 2;19(1):75.
doi: 10.1186/s12882-018-0870-0.

Effects of dialysate to serum sodium (Na+) alignment in chronic hemodialysis (HD) patients: retrospective cohort study from a quality improvement project

Jochen G Raimann  1 , Linda H Ficociello  2 , Len A Usvyat  3   2 , Hanjie Zhang  3 , Lisa Pacelli  3 , Sandi Moore  3   2 , Penny Sheppard  3 , Qingqing Xiao  3 , Yuedong Wang  4 , Claudy Mullon  2 , Paul Balter  3 , Terry Sullivan  3 , Peter Kotanko  3
Affiliations
Observational Study

Effects of dialysate to serum sodium (Na+) alignment in chronic hemodialysis (HD) patients: retrospective cohort study from a quality improvement project

Jochen G Raimann et al. BMC Nephrol. .

Abstract

Background: Evidence indicates favorable effects of dialysate (DNa+) to serum sodium concentration (SNa+) alignment, however, results from larger sample populations are needed. For this reason, we conducted a retrospective propensity score-matched cohort study from a quality improvement project to investigate the effects of alignment on population of maintenance hemodialysis patients.

Methods: At 4 participating hemodialysis (HD) clinics, patients with SNa+ lower than the standard DNa+ of 137 mEq/L who received HD with DNa+ aligned to the average of the last 4 SNa+ measurements were evaluated (clinicaltrials.gov # NCT01825590 ). In this retrospective data analysis, an intention-to-treat (primary) and an as-treated "intervention" (secondary) cohort were created. "Aligned" patients from both cohorts (N = 163 for the primary and N = 137 for the secondary) were then propensity-score matched in a 1:1 fashion to "unaligned" patients from the Renal Research Institute database. The propensity score was generated based on age, gender, white race, Hispanic ethnicity, absence or presence of diabetes, hemodialysis vintage, interdialytic weight gain (IDWG; as a percentage of postdialysis body weight), catheter as primary dialysis access, predialysis systolic blood pressure, serum sodium concentration, hospitalization count during baseline. T-Test was employed for group comparisons of changes to the primary (volume-related and hemodynamic parameters) and tertiary outcomes. All-cause and fluid overload-related hospitalization admission rates were compared using Wilcoxon Rank Sum test and Cox regression analysis for repeated events.

Results: In the primary analysis, aligned and unaligned subjects showed comparable demographics at baseline. Treatment effects were significant for IDWG [-0.12 (95% CI -0.24 to 0) L] and showed decreasing non-significant trends for pre-dialysis hemodynamic parameters. Count comparison and Cox regression analysis showed no clear advantage of alignment in terms of all-cause and fluid overload-related hospitalization.

Conclusions: Results from the largest sodium alignment program to date suggest positive treatment effects on volume-related and hemodynamic parameters, but no clear effect on risk of hospitalization. Well-matched control patients minimized confounding effects. Small effects and lack of significant differences may be explained by a low baseline DNa+ limiting the interventional change.

Keywords: Blood pressure; Dialysate to serum sodium alignment; Interdialytic weight gain; Sodium mass balance.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This manuscript reports data from a retrospective analysis of a quality improvement project. The Renal Research Institute was formed as a joint-venture between Fresenius Medical Care North America and Beth Israel Medical Center (until 2010) and does not have an ethics committee. - Therefore the Institutional Review Board (IRB) at Beth Israel Medical Center acted as the local IRB for this study and has waived the need for review and determined this study as exempt under the provisions of 45 CFR 46 Section 101(b) as per the United States Health Insurance Portability and Accountability Act.

Consent for publication

Not applicable.

Competing interests

LHF and CM are employees of Fresenius Medical Care, North America. CM and PK hold stock in Fresenius Medical Care NA. All other authors have no relevant financial disclosures.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Distribution of pre hemodialysis dialysate to serum sodium gradient (pre HD GNa+) before and after prior to intervention start and in the control group
Fig. 2
Fig. 2
Distribution of interdialytic weight gain (IDWG) before and after prior to intervention start and in the control group
Fig. 3
Fig. 3
Distribution of pre hemodialysis systolic blood pressure (pre HD SBP) before and after prior to intervention start and in the control group
See this image and copyright information in PMC

References

    1. Hecking M, Kainz A, Horl WH, Herkner H, Sunder-Plassmann G. Sodium setpoint and sodium gradient: influence on plasma sodium change and weight gain. Am J Nephrol. 2011;33(1):39–48. doi: 10.1159/000322572. - DOI - PubMed
    1. Keen ML, Gotch FA. The association of the sodium "setpoint" to interdialytic weight gain and blood pressure in hemodialysis patients. Int J Artif Organs. 2007;30(11):971–979. doi: 10.1177/039139880703001105. - DOI - PubMed
    1. Port FK, Johnson WJ, Klass DW. Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int. 1973;3(5):327–333. doi: 10.1038/ki.1973.51. - DOI - PubMed
    1. Rodrigo F, Shideman J, McHugh R, Buselmeier T, Kjellstrand C. Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. Ann Intern Med. 1977;86(5):554–561. doi: 10.7326/0003-4819-86-5-554. - DOI - PubMed
    1. Hecking M, Karaboyas A, Saran R, Sen A, Inaba M, Rayner H, Horl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, et al. Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol. 2012;7(1):92–100. doi: 10.2215/CJN.05440611. - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data